N/A N=40

An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms

Pancreatic Endocrine Neoplasms

Bottom Line

View on ClinicalTrials.gov: NCT02400996 ↗

Enrolled (actual)

Serious AEs

15.0%

Results posted

Apr 2015

Primary outcome: Primary: Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms — 28; 12; 22; 18 participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Pediatric, Adult, Older Adult
Sex: All
Sponsor: Medical College and Hospital Kolkata
Primary completion: Jun 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms	28; 12; 22; 18	—

Summary

A single institutional study of Pancreatic Endocrine Neoplasms over 18 years.

Eligibility Criteria

Inclusion Criteria

Pathological reports and Prooperative CAT Scan showing Endocrine Pancreatic Tumours

Exclusion Criteria

Nonendocrine Pancreatic Tumours

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02400996). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.